M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer

The efficacy of PD-1/PD-L1 blockades is heterogeneous in different molecular subtypes of gastric cancer (GC). In this study, we analyzed relevant clinical trials to identify the molecular subtypes associated with the efficacy of PD-1/PD-L1 blockades, and public datasets, patient samples, and GC cell...

Full description

Bibliographic Details
Main Authors: Rui Zhao, Qianyi Wan, Yong Wang, Yutao Wu, Shuomeng Xiao, Qiqi Li, Xiaoding Shen, Wen Zhuang, Yong Zhou, Lin Xia, Yinghan Song, Yi Chen, Hanshuo Yang, Xiaoting Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1862520